Sanofi S.A. is a French multinational pharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers.
Feb 28, 2018 ... Discover Sanofi: a global biopharmaceutical company focused on human health.
Find Sanofi US corporate information, pharmaceutical products, news, career opportunities and health resources.
Sanofi, incorporated on May 11, 1994, is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company's segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the ...
Stock analysis for Sanofi (SAN:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Company profile & key executives for Sanofi SA (SQ:-) including description, corporate address, management team and contact info.
Latest Sanofi SA (SAN:PAR) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Drug Giant Sanofi May Be Getting Ready to Buy Up This Rare Disease Company April 28, 2017. The FDA Just Approved the First Ever Drug to Treat Severe MS March 29, 2017. Sanofi, Regeneron Win FDA Approval for Eczema Drug With Multi-Billion Dollar Potential March 28, 2017. These Were the 10 Biggest ...
Mar 15 / Zacks.com - Paid Partner Content. Is Sanofi (SNY) a Great Stock for Value Investors? Mar 19 / Zacks.com - Paid Partner Content. Biotech Stock Roundup: REGN Cuts Praluent Price, OREX to File for Bankruptcy. Mar 14 / Zacks.com - Paid Partner Content. The Zacks Analyst Blog Highlights: AT&T, Goldman Sachs, ...